MedTrace Logo

BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

NCT02657486 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2026-02-09

No results posted yet for this study

Summary

The purpose of this study is to study the activity and effects of BGJ398 on bladder cancer tumors that are confined to the lining of the bladder.

Conditions

Interventions

DRUG

BGJ398

Sponsors & Collaborators

Principal Investigators

  • Jonathan Rosenberg, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-06
Primary Completion
2026-02-04
Completion
2026-02-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02657486 on ClinicalTrials.gov